Ibrutinib for First-Line Treatment of Chronic Lymphocytic Leukemia in Patients Aged 65 Year of Age: Results with 5 Years of Follow-Up for the RESONATE-2 Study

Alessandra Tedeschi, Jan A. Burger,Paul Barr,Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen,Steven Coutre, Stephen Devereux, Sebastian Grosicki, Helen McCarthy, Jianyong Li, David Simpson, Fritz Offner, Carol Moreno, Xiaoxian Dai, Indu Lal, James Dean, Thomas J. Kipps

Leukemia & lymphoma/Leukemia and lymphoma（2020）

引用 0|浏览70

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要